Nucynta Extended-Release 200 mg (Tapentadol (Tapentadol Hydrochloride) TABLET (EXTENDED-RELEASE)) 200 MG

NUCYNTA Extended-Release 200 MG tablets provide long-lasting pain relief. This extended-release formulation of tapentadol hydrochloride is designed for consistent management of moderate to severe pain. Ideal for those seeking prolonged relief, this medication is manufactured by Endo Operations Ltd. in Ireland.

Strength

200 MG

Pack Size

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NUCYNTA Extended-Release 200 MG tablets are primarily used for the management of moderate to severe pain. The extended-release formulation ensures a steady release of tapentadol hydrochloride, providing sustained pain relief over an extended period. This medication is often considered for conditions requiring long-term pain management, such as chronic pain or post-surgical recovery.

Side Effects

Common effects of NUCYNTA Extended-Release 200 MG tablets may include drowsiness, dizziness, nausea, and constipation. Some users may experience headaches or dry mouth. These effects can vary from person to person and may subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

NUCYNTA Extended-Release 200 MG tablets should be handled with care. They are designed to release medication slowly over time and should not be crushed, chewed, or broken. This can lead to an overdose. Store the medication in a safe place, away from children and pets. Follow the prescribed dosage and administration instructions carefully.

Avoid Interactions

NUCYNTA Extended-Release 200 MG tablets may interact with other medications, including alcohol, antidepressants, and certain pain relievers. Combining this medication with alcohol or other central nervous system depressants can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

NUCYNTA Extended-Release 200 MG tablets are used for the management of moderate to severe pain, providing sustained relief over an extended period.

NUCYNTA Extended-Release 200 MG tablets should be taken whole, with water, and should not be crushed, chewed, or broken. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include drowsiness, dizziness, nausea, and constipation. These effects can vary and may subside as the body adjusts to the medication.

It is generally advised to avoid alcohol while taking NUCYNTA Extended-Release 200 MG tablets, as it can increase the risk of side effects.

Store NUCYNTA Extended-Release 200 MG tablets in a safe place, away from children and pets, at room temperature.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.